¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼ö¼ú¿ë ºÕ ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ:
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é ¼¼°è ¼ö¼ú¿ë ºÕ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 6¾ï 1,837¸¸ ´Þ·¯¿¡ ´ÞÇϰí, CAGRÀº 5.21%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ¼ö¼ú½Ç ±â´É Çâ»óÀ» À§ÇØ ÀÇ·á ÀÎÇÁ¶ó Àü¹Ý¿¡ °ÉÃÄ ¼ö¼ú¿ë ºÕÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¶ÇÇÑ, ¸¹Àº º´¿ø°ú ¿Ü·¡ ¼ö¼ú Ŭ¸®´ÐÀÌ ÃֽŠÀåºñ °ü¸® ½Ã½ºÅÛÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ¼öÇàµÇ´Â ¿Ü°ú ¼ö¼úÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀåÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù.
¼ö¼ú¿ë ºÕÀº ÀϹÝÀûÀ¸·Î »ê¼Ò, Áú¼Ò, ÀÌ»êÈź¼Ò¿Í °°Àº ÀÇ·á¿ë °¡½º, Àü·Â, AV µ¥ÀÌÅÍ ¼ºñ½º¿¡ ´ëÇÑ ºü¸¥ ¾×¼¼½º°¡ ÇÊ¿äÇÑ ÀÇ·á ½Ã¼³¿¡¼ »ç¿ëµË´Ï´Ù. ºÕÀº ÇöÀç ¼ö¼ú±â±¸¸¦ Á¤¸®Çϰí Áß¾Ó ÁýÁß½ÄÀ¸·Î °ü¸®Çϰí, Äڵ带 ¹æÇØÇÏÁö ¾Ê°í °É·Á ³Ñ¾îÁú À§ÇèÀ» ÁÙÀ̰í, ¼±¹ÝÀ» Á¦°øÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº Çõ½ÅÀûÀÌ°í ¸ÂÃãÇü Á¦Ç°À» Ãâ½ÃÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼ö¼ú¿ë ºÕ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 12¿ù ½ºÄ«ÀÌÆ®·Ð(Skytron LLC)Àº ºê·¹ÀÌÅ©¿Í ¹öưÀ» ´©¸¦ Çʿ䰡 ¾ø´Â µî »õ·Ó°í °³¼±µÈ ǰÁúÀ» °®Ãá ÇÁ¸®´ý ºÕ(Freedom Boom)À» Ãâ½ÃÇß½À´Ï´Ù. ±¹Á¦¹Ì¿ë¼ºÇü¿Ü°úÇÐȸ(ISAPS)´Â ¿¬·Ê '¹Ì¿ë¼ºÇü/¹Ì¿ë½Ã¼ú¿¡ ´ëÇÑ ¼¼°è Á¶»ç' °á°ú¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ¿¡ µû¸£¸é 2021³â¿¡ ¼ºÇü¿Ü°ú Àǻ簡 ½ÃÇàÇÏ´Â ¼ö¼ú °Ç¼ö´Â Àü ¼¼°èÀûÀ¸·Î 1,280¸¸ °ÇÀ» ³Ñ¾î Àü³â ´ëºñ 19.3% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.
¼ö¼ú¿ë ºÕ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- Á¦Ç° À¯Çüº°·Î´Â ¸¶Ãë¿ë ºÕÀÌ 2022³â 52.12%·Î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- ¼³Ä¡º°·Î´Â ÁöºØ ÀåÂøÇüÀÌ 2022³â 59.87%·Î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ³ôÀº ÆíÀǼº°ú ¼ö¼ú½Ç¿¡ ¸¹Àº °ø°£À» ÇÊ¿ä·Î ÇÏÁö ¾Ê´Â Á¡ µîÀÌ ¼ºÀå ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
- ÃÖÁ¾ ¿ëµµº°·Î´Â º´¿ø ºÎ¹®ÀÌ ¿¹Ãø ±â°£ µ¿¾È 29.90%ÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
- ºÏ¹Ì´Â 2022³â 30.9%·Î ½ÃÀåÀ» µ¶Á¡Çߴµ¥, ÀÌ´Â À¯¸®ÇÑ È¯±Þ°ú ¿¬±¸ ¹× ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ´Â Á¤ºÎ ¹× ºñÁ¤ºÎ Â÷¿øÀÇ ³ë·Â¿¡ ±âÀÎÇÑ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àα¸°¡ ¸¹°í, ¼¼°è °æÁ¦·ÂÀÌ ¼±Áø±¹¿¡¼ ½ÅÈï±¹À¸·Î À̵¿ÇÏ¸é¼ ÀÇ·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀ¸·Î ÃßÁ¤µË´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¼ö¼ú¿ë ºÕ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óºÎ ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
- º¸±Þ°ú ¼ºÀå Àü¸Á ¸ÅÇÎ
- ¾÷°èÀÇ ¹ë·ùüÀÎ ºÐ¼®
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ¼ö¼ú¿ë ºÕ ½ÃÀå ºÐ¼® Åø
- ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå ¼ö¼ú¿ë ºÕ ½ÃÀå : Á¦Ç° À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®
- Á¦Ç° À¯Çü ½ÃÀå Á¡À¯À², 2022³â¡¤2030³â
- ºÎ¹® ´ë½Ãº¸µå
- Á¦Ç° À¯Çüº° ¼ö¼ú¿ë ºÕ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
Á¦5Àå ¼ö¼ú¿ë ºÕ ½ÃÀå : ¼³Ä¡ ÃßÁ¤¡¤µ¿Ç⠺м®
- ¼³Ä¡ ½ÃÀå Á¡À¯À², 2022³â¡¤2030³â
- ºÎ¹® ´ë½Ãº¸µå
- ¼³Ä¡º° ¼ö¼ú¿ë ºÕ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
Á¦6Àå ¼ö¼ú¿ë ºÕ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2022³â¡¤2030³â
- ºÎ¹® ´ë½Ãº¸µå
- ÃÖÁ¾ ¿ëµµº° ¼ö¼ú¿ë ºÕ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
Á¦7Àå ¼ö¼ú¿ë ºÕ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
- Áö¿ª ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â¡¤2030³â
- Áö¿ª ½ÃÀå ´ë½Ãº¸µå
- ¼¼°è ½ÃÀå ÇöȲ
- Áö¿ª ½ÃÀå Á¡À¯À²°ú ÁÖ¿ä ±â¾÷, 2022³â
- 2018-2030³â ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, µ¿Ç⠺м®
- ºÏ¹Ì
- ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Àεµ
- Áß±¹
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ¾Æ¸£ÇîÆ¼³ª
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- Äí¿þÀÌÆ®
Á¦8Àå °æÀï »óȲ
- ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
- ȸ»ç/°æÀï ºÐ·ù
- º¥´õ »óȲ
- List of key distributors and channel partners
- Key customers
- Key company market share analysis, 2022
- STERIS
- Baxter International Inc.
- Amico Group of Companies
- Stryker
- Zimmer Biomet
- Getintage AB
- Ondal Medical Systems
- SKYTRON, LLC
- Dragerwerk AG &Co. KGaA
ksm 23.11.01
Surgical Booms Market Growth & Trends:
The global surgical booms market size is estimated to reach USD 618.37 million by 2030, registering a CAGR of 5.21%, according to a new report by Grand View Research, Inc.. One of the major factors that drives the market growth includes the increasing adoption of surgical booms throughout the healthcare infrastructure which aims to enhance functionality of operating rooms. Additionally, many hospitals and ambulatory surgery clinics are adopting contemporary equipment management systems. The rising number of surgical procedures performed around the world is creating lucrative growth for the market.
Surgical booms are typically utilized in healthcare facilities that require quick access to medical gases like oxygen, nitrogen, and carbon dioxide as well as electrical power and audio-visual data services. Booms are now vital for organizing and centralizing surgical equipment, keeping cords out of the way to lessen tripping hazards, and providing shelves. These factors would further drive the market growth.
Leading market players are introducing innovative and customizable products which are further boosting the demand for surgical booms. For instance, in Dec 2020, the Skytron LLC launched the freedom boom bringing new and improved qualities like no brakes or buttons to push. The International Society of Aesthetic Plastic Surgery (ISAPS) has revealed the findings of its annual Global Survey on Aesthetic/Cosmetic Procedures, which show that plastic surgeons would perform more than 12.8 million surgical procedures globally in 2021, a 19.3% rise over the previous year.
Surgical Booms Market Report Highlights:
- Based on product type the anesthesia booms segment accounted for the largest market share of 52.12% in 2022 as these are frequently used in hospital settings or any hybrid operating room
- Based on installation, the roof-mounted segment held the largest market share of 59.87% in 2022 and the growth is attributed to factors such as its convenience and does not require lots of space in the operation room
- Based on end-use, the hospitals segment held the largest market share of 29.90% over the forecast period
- North America dominated the market at 30.9% in 2022 owing to factors such as favorable reimbursement and government & non-government initiatives to boost research and innovation
- Asia Pacific has been estimated to be the fastest growing region due to the large population, increasing healthcare awareness as global economic power shifts away from developed countries towards emerging ones
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Installation
- 1.1.3. End-Use
- 1.1.4. Region
- 1.1.5. Estimates and forecast timeline.
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Installation outlook
- 2.2.3. End-Use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Surgical Booms Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Increasing adoption of surgical booms in healthcare infrastructure for improving operating room
- 3.4.1.2. Rising in number of surgeries
- 3.4.1.3. Increasing adoption of modern equipment systems.
- 3.4.2. Market restraint analysis
- 3.4.2.1. High cost associated with surgical boom
- 3.5. Surgical Booms Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.2.4. Major Deals & Strategic Alliances Analysis
- 3.5.2.5. Market Entry Strategies
Chapter 4. Surgical Booms Market: Product Type Estimates & Trend Analysis
- 4.1. Product Type Market Share, 2022 & 2030
- 4.2. Segment Dashboard
- 4.3. Surgical Booms Market by Product Type Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Equipment Boom
- 4.4.1.1. Equipment Boom market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.2. Anesthesia Boom
- 4.4.2.1. Anesthesia Boom market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.3. Other Boom
- 4.4.3.1. Other Boom market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Surgical Booms Market: Installation Estimates & Trend Analysis
- 5.1. Installation Market Share, 2022 & 2030
- 5.2. Segment Dashboard
- 5.3. Surgical Booms Market by Installation Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Floor Mounted
- 5.4.1.1. Floor Mounted market estimates and forecast 2018 to 2030 (USD Million)
- 5.4.2. Roof Mounted
- 5.4.2.1. Roof Mounted market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Surgical Booms Market: End-Use Estimates & Trend Analysis
- 6.1. Mobility Market Share, 2022 & 2030
- 6.2. Segment Dashboard
- 6.3. Surgical Booms Market by End-Use Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Hospitals
- 6.4.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
- 6.4.2. Ambulatory Surgical Centers
- 6.4.2.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
- 6.4.3. Dental Clinics
- 6.4.3.1. Dental clinics market estimates and forecast 2018 to 2030 (USD Million)
- 6.4.4. Others
- 6.4.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Surgical Booms Market: Regional Estimates & Trend Analysis
- 7.1. Regional market share analysis, 2022 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2022
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. MEA
- 7.5. Market Estimate & Forecasts and Trend Analysis, 2018 to 2030
- 7.6. North America
- 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. U.S.
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 7.6.3. Canada
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
- 7.7. Europe
- 7.7.1. UK
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Competitive Scenario
- 7.7.1.3. Regulatory framework
- 7.7.1.4. Reimbursement scenario
- 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
- 7.7.2. Germany
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
- 7.7.3. France
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. France market estimates and forecasts, 2018 - 2030
- 7.7.4. Italy
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
- 7.7.5. Spain
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory framework
- 7.7.5.4. Reimbursement scenario
- 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
- 7.7.6. Denmark
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory framework
- 7.7.6.4. Reimbursement scenario
- 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 7.7.7. Sweden
- 7.7.7.1. Key country dynamics
- 7.7.7.2. Competitive Scenario
- 7.7.7.3. Regulatory framework
- 7.7.7.4. Reimbursement scenario
- 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 7.7.8. Norway
- 7.7.8.1. Key country dynamics
- 7.7.8.2. Competitive Scenario
- 7.7.8.3. Regulatory framework
- 7.7.8.4. Reimbursement scenario
- 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
- 7.8. Asia Pacific
- 7.8.1. Japan
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Competitive Scenario
- 7.8.1.3. Regulatory framework
- 7.8.1.4. Reimbursement scenario
- 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
- 7.8.2. India
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory framework
- 7.8.2.4. Reimbursement scenario
- 7.8.2.5. India market estimates and forecasts, 2018 - 2030
- 7.8.3. China
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory framework
- 7.8.3.4. Reimbursement scenario
- 7.8.3.5. China market estimates and forecasts, 2018 - 2030
- 7.8.4. South Korea
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory framework
- 7.8.4.4. Reimbursement scenario
- 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 7.8.5. Australia
- 7.8.5.1. Key country dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory framework
- 7.8.5.4. Reimbursement scenario
- 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
- 7.8.6. Thailand
- 7.8.6.1. Key country dynamics
- 7.8.6.2. Competitive Scenario
- 7.8.6.3. Regulatory framework
- 7.8.6.4. Reimbursement scenario
- 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
- 7.9. Latin America
- 7.9.1. Brazil
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Competitive Scenario
- 7.9.1.3. Regulatory framework
- 7.9.1.4. Reimbursement scenario
- 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 7.9.2. Mexico
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory framework
- 7.9.2.4. Reimbursement scenario
- 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
- 7.9.3. Argentina
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory framework
- 7.9.3.4. Reimbursement scenario
- 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
- 7.9.4. MEA
- 7.9.5. South Africa
- 7.9.5.1. Key country dynamics
- 7.9.5.2. Competitive Scenario
- 7.9.5.3. Regulatory framework
- 7.9.5.4. Reimbursement scenario
- 7.9.5.5. South Africa market estimates and forecasts, 2018 - 2030
- 7.9.6. Saudi Arabia
- 7.9.6.1. Key country dynamics
- 7.9.6.2. Competitive Scenario
- 7.9.6.3. Regulatory framework
- 7.9.6.4. Reimbursement scenario
- 7.9.6.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 7.9.7. UAE
- 7.9.7.1. Key country dynamics
- 7.9.7.2. Competitive Scenario
- 7.9.7.3. Regulatory framework
- 7.9.7.4. Reimbursement scenario
- 7.9.7.5. UAE market estimates and forecasts, 2018 - 2030
- 7.9.8. Kuwait
- 7.9.8.1. Key country dynamics
- 7.9.8.2. Competitive Scenario
- 7.9.8.3. Regulatory framework
- 7.9.8.4. Reimbursement scenario
- 7.9.8.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2022
- 8.3.4. STERIS
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Baxter International Inc.
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Amico Group of Companies
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Stryker
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Zimmer Biomet
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Getintage AB
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Ondal Medical Systems
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. SKYTRON, LLC
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Dragerwerk AG & Co. KGaA
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives